Quantitative and qualitative proteome characteristics extracted from in-depth integrated genomics and proteomics analysis by Low, T.Y. et al.
Cell Reports
ResourceQuantitative and Qualitative Proteome
Characteristics Extracted from In-Depth
Integrated Genomics and Proteomics Analysis
Teck Yew Low,1,2,6 Sebastiaan van Heesch,3,6 Henk van den Toorn,1,2,6 Piero Giansanti,1,2 Alba Cristobal,1,2 Pim Toonen,3
Sebastian Schafer,4 Norbert Hu¨bner,4,5 Bas van Breukelen,1,2 Shabaz Mohammed,1,2,7 Edwin Cuppen,3,*
Albert J.R. Heck,1,2,* and Victor Guryev3,8
1Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical
Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, the Netherlands
2Netherlands Proteomics Center, Padualaan 8, 3584 CH Utrecht, the Netherlands
3Hubrecht Institute-KNAW & University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, the Netherlands
4Max-Delbruck-Center for Molecular Medicine (MDC), Robert-Rossle-Strasse 10, 13125 Berlin, Germany
5DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany
6These authors contributed equally to this work
7Present address: Departments of Chemistry and Biochemistry, University of Oxford, Physical & Theoretical Chemistry Laboratory,
South Parks Road, OX1 3QZ Oxford, UK
8Present address: European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen,
Antonius Deusinglaan, 1, Building 3226, 9713 AV Groningen, the Netherlands
*Correspondence: e.cuppen@hubrecht.eu (E.C.), a.j.r.heck@uu.nl (A.J.R.H.)
http://dx.doi.org/10.1016/j.celrep.2013.10.041
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works
License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are
credited.SUMMARY
Quantitative and qualitative protein characteristics
are regulated at genomic, transcriptomic, and post-
transcriptional levels. Here, we integrated in-depth
transcriptome and proteome analyses of liver tissues
from two rat strains to unravel the interactions within
and between these layers. We obtained peptide evi-
dence for 26,463 rat liver proteins. We validated
1,195 gene predictions, 83 splice events, 126 pro-
teins with nonsynonymous variants, and 20 isoforms
with nonsynonymous RNA editing. Quantitative RNA
sequencing and proteomics data correlate highly
between strains but poorly among each other, indi-
cating extensive nongenetic regulation. Our multi-
level analysis identified a genomic variant in the
promoter of the most differentially expressed gene
Cyp17a1, a previously reported top hit in genome-
wide association studies for human hypertension,
as a potential contributor to the hypertension pheno-
type in SHR rats. These results demonstrate the
power of and need for integrative analysis for under-
standing genetic control of molecular dynamics and
phenotypic diversity in a system-wide manner.
INTRODUCTION
Mass spectrometry (MS)-based proteomics and next-genera-
tion sequencing (NGS) are rapidly maturing techniques, eachCell Reenabling comprehensive measurements of gene products at a
system level (Altelaar et al., 2013; Cox and Mann, 2011; Soon
et al., 2013). Although MS and NGS are highly complementary,
they are still rarely applied integrated in large-scale studies
(Ning et al., 2012). State-of-the-art MS approaches can currently
identify over 10,000 proteins in a single experiment (Munoz et al.,
2011; Nagaraj et al., 2011), which brings the analysis of complete
proteomes within reach (Ahrens et al., 2010; Cox and Mann,
2011). However, as long as noncustomary protein databases
that are derived from (typically incomplete) reference genome
assemblies and annotations remain the sole source used for
MS spectra matching, true completeness will not be reached.
For example, protein isoforms arising from genetic polymor-
phisms, posttranscriptional events such as RNA-editing and
posttranslational modifications are largely missed (Jensen,
2004; Uhlen and Ponten, 2005).
Recent advances in NGS techniques, including whole genome
sequencing (WGS) and total RNA sequencing (RNA-seq) allow
for the generation of near-complete inventories of genetic varia-
tion in a system and its transcribed repertoire (Ozsolak and
Milos, 2011). However, from such analyses, the effects on the
proteins cannot be predicted with high confidence. For example,
the consequence of a single nucleotide variant (SNV) on the
coding capacity of a transcript can be predicted accurately,
but not the potential effect on the stability of the corresponding
protein. Systematic comparison of RNA-seq data with genomic
data reveals another layer of complexity. It has now been
convincingly demonstrated that certain transcripts are modified
by posttranscriptional editing, primarily by targeted A to I deam-
ination (Farajollahi and Maas, 2010). Most likely, all these types
of variation will not only affect the composition and function ofports 5, 1469–1478, December 12, 2013 ª2013 The Authors 1469
a protein, but also influence expression levels. However, addi-
tional layers of translation control may dampen or completely
abolish such effects (Kleinman and Majewski, 2012; Lin et al.,
2012; Pickrell et al., 2012).
An integrative analysis of different data modalities, ideally
derived from samples of a single source, is required for correctly
deciphering the effects of genomic and transcriptomic variation
on molecular processes and cellular functioning. An example of
such data integration is the use of proteomic data derived from
MS in combination with complete genome data to improve
gene annotation (Jaffe et al., 2004; Renuse et al., 2011). This
approach has so far been sparsely performed and mainly in
organisms with smaller genomes (Merrihew et al., 2008; Venter
et al., 2011). On the other hand, integrative investigations of
messenger RNA levels and the proteins they encode reveal
only modest correlations, implying an unresolved level of
complexity in regulation of expression (Nesvizhskii et al., 2006;
Ning et al., 2012; Schwanha¨usser et al., 2011; de Sousa Abreu
et al., 2009; Vogel and Marcotte, 2012).
For this study, we selected two rat inbred strains BN-Lx/Cub
(BN-Lx) and SHR/OlaIpcv (SHR) (Printz et al., 2003), representing
widely studied, renewable, and genetically homogeneous re-
sources. Both strains have previously been extensively charac-
terized at the genomic (Atanur et al., 2010; Gibbs et al., 2004)
and phenotypic level (Hubner et al., 2005; Johnson et al., 2009;
Pravenec and Kurtz, 2010; Simonis et al., 2012). The BN-Lx
strain is derived from, and thus very closely related to, the Brown
Norway (BN) strain. The latter strain was used for creating the
rat reference genome assembly (Gibbs et al., 2004) and is
commonly used as the protein reference data set in rat prote-
omics studies. The spontaneously hypertensive rat (SHR) is
more diverged from BN and is a widely used disease model for
hypertension studies. Whereas several blood pressure quantita-
tive trait loci (QTLs) have been mapped to the SHR genome, no
functional variants driving elevated blood pressure have been
validated to date. Here, we combine in-depth genomic, tran-
scriptomic, and proteomic analyses from inbred rats of two
different genetic backgrounds using the same sets of rat liver tis-
sues (Figure 1A). The liver is a large and relatively homogeneous
tissue source that is well known to be involved in both hyperten-
sion and metabolic syndrome - the phenotypes associated with
the SHR strain. We determine quantitative and qualitative molec-
ular dynamics at different functional levels and achieve a level of
proteome completeness by adding variation information derived
from WGS and RNA-seq data. These data allow us to apply a
genome-wide genetic-genomics approach (Jansen and Nap,
2001) to start understanding multilevel systems regulation and
to identify candidate genes that are potentially involved in the
hypertension phenotype of the SHR rat.
RESULTS AND DISCUSSION
Extension of the Rat Protein Database
In proteomics, tandem mass spectra are typically annotated by
searching against in silico-generated spectra based on a pub-
licly available protein database. For rat, such a database is
derived from the reference genome assembly of the BN rat
(Gibbs et al., 2004). To create a sample-specific database for1470 Cell Reports 5, 1469–1478, December 12, 2013 ª2013 The AutMS peptide searching, we extended the existing RefSeq-based
peptide database by incorporating strain-specific peptides and
predicted peptides. We first obtained all strain-specific genetic
variation of the BN-Lx and SHR strains including single nucleo-
tide variants (SNVs) and in-frame indels.
Most genomic SNVs are located in the noncoding sequences,
and only the less frequent nonsynonymous variants in coding re-
gions give rise to altered amino acid sequences (Hurst et al.,
2009; Su et al., 2011; Valentine et al., 2006). We collected
10,493 nonsynonymous variants from recently generated high-
coverage WGS data of the BN-Lx and SHR genomes (Atanur
et al., 2010; Simonis et al., 2012), which are predicted to affect
6,187 protein isoforms derived from 4,566 genes. Furthermore,
to be able to detect in silico gene predictions using the prote-
omics data as evidence (Volkening et al., 2012), we added
44,993 GENSCAN gene predictions to our rat database (Burge
and Karlin, 1997).
Next, we performed RNA-seq (Table S1) on RNA extracted
from liver tissue of both rat strains (two males and two females
per strain). To this end, paired-end sequencing data were gener-
ated to construct de novo transcriptome assemblies for each
strain, In total, we found expression evidence for 18,116 known
genes (12,052 with fragments per kilobase of exon per million
fragments mapped [FPKM] >1), of which 2,612 (1,820 with
FPKM >1) overlap the nonsynonymous variants previously
detected by genome resequencing. Also, we identified 2,545
transcript splicing events affecting 1,015 genes. Although the
majority of the identified splice events (1,687) were detected in
both strains, 220 and 638 events were specific to BN-Lx and
SHR rats, respectively (Table S2). Independent RT-PCR-based
Sanger sequencing confirmed 74.1% (43 out of the 58 suc-
cessful PCR assays) of a randomly sampled subset as true
transcript isoforms (Table S3A). In addition, the same transcrip-
tome assembly data provided expression evidence for 2,903
GENSCAN predictions (Table S4).
The de novo assembled transcriptome data also allow for
characterization of transcriptomes at nucleotide resolution.
Because both BN-Lx and SHR strains are fully inbred, observed
changes at the transcript level are unlikely to be allele-specific
variation and can thus be attributed to technical artifacts (intro-
duced during sequencing or mapping) or to RNA editing (Farajol-
lahi and Maas, 2010). We find a total of 799 canonical (A to I or
C to T) RNA-editing variants (Table S5) of which 176 and 354
are specifically observed in BN-Lx and SHR, respectively. As ex-
pected, a large proportion of edits resides in the noncoding UTR
parts of transcripts or do not change the coding capacity of a
transcript. Yet, theymight be affecting RNA secondary structure,
stability, or miRNA binding. Only 196 edits were nonsynonymous
and therefore included in our protein database as potentially
detectable by MS. Of a subset of 169 candidate editing events
tested by independent RT-PCR-based amplicon resequencing,
most (104) showed reads corresponding to expected edited
transcripts, and another 12 likely represent germline variants
that missed detection during genome resequencing (Table S3B).
All peptide variants and isoforms derived from genome and
transcriptome variation and all newly predicted peptides based
on GENSCAN and de novo transcriptome assembly data were
appended to the Ensembl rat database (3.4.63) to create ourhors
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Figure 1. Integrated Proteomics, Genomics,
and Transcriptomics to Improve Sample-
Specific Protein Identification
(A) Schematic representation of the integrated
genome and proteome analysis of BN-Lx and SHR
rat liver using NGS and deep-proteome profiling.
(B) Bar plot showing the percentage of the current
reference database that is covered by the ex-
perimentally derived proteomes, with respect to
recent other proteomics efforts (Sun et al., 2010).
For BN-Lx and SHR, 39.7% of the Ensembl data-
base is represented (13,088 out of 32,971 entries;
release 3.4.63). The human liver proteome gener-
ated by the Chinese Human Liver Proteome
Profiling Consortium cover 13.5% of the IPI human
database (version 3.07; 7,050 out of 50,225
entries).
(C) Diagram displaying identified proteins specific
to BN-Lx (blue), SHR-specific proteins (red), and
proteins shared between both strains (green).
(D) Relative contribution (%) to the BN-Lx and SHR
rat proteomes (containing unique peptides) of each
additional layer of genomics- and transcriptomics-
derived protein variants.
See also Tables S1, S2, S3, S4, S5, S6, S8, S9, S10,
S11, and S12.customized RAT_COMBINED database, which was used for all
subsequent proteomic analyses.
Proteomics Analysis
We generated proteomics data with the same liver tissues used
for RNA-seq. Each lysate was proteolyzed with five orthogonal
proteases, and the resulting 36 SCX fractions per digest wereCell Reports 5, 1469–1478, Deanalyzed with LC-MS/MS, cumulating in
180 runs per strain, yielding 12 million
tandem MS spectra. By using multiple
proteases, not only the identification and
sequence coverage of each protein in-
crease, but also the chance of capturing
evidence for predicted peptides/proteins
and consequences of RNA editing (Mo-
hammed et al., 2008; Peng et al., 2012;
Swaney et al., 2010). To ensure compre-
hensive coverage, two different but
complementary algorithms for spectra-
to-peptide assignment were applied.
First, Mascot search engine was used
for database searching. Next, remaining
unassigned spectra were processed
with PEAKS Studio 6.0 which incorpo-
rates a proprietary de novo sequencing
algorithm. The large amount of data
allowed us to apply a false discovery
rate (FDR) filter of 0% (q = 0) and
still identify over 2 million peptide-
spectral matches (PSMs), corresponding
to 175,000 nonredundant peptides
(Tables S6A and S6B). By performing amerged BN-Lx and SHR data set search against our custom
RAT_COMBINED database, we obtained peptide evidence for
26,463 database entries. Of these, 18,322 are shared between
BN-Lx and SHR (Figure 1C; Table S7), whereas 3,009 and
5,132 appear strain specific for SHR and BN-Lx, respectively.
For comparison, we counted the number of identifications
matching entries in the Ensembl database (3.4.63), disregardingcember 12, 2013 ª2013 The Authors 1471
the variants. Out of the 32,971 original database entries, 13,088
were matched, representing 39.7% of database entries. In
contrast, the most extensive liver proteome so far (the human
liver proteome generated by the Chinese Human Liver Proteome
Profiling Consortium) covers only 13.5% of the human IPI data-
base (version 3.07; 50,225 entries), illustrating the depth of our
data (Figure 1B; Table S6D). Over 86.5% of all proteins could
be supported by evidence of gene expression in the RNA-seq
data. As expected, identified peptides are evenly distributed
over the rat chromosomes, concordant with the distribution of
genes and transcripts (Figure S1A). The median coverage of all
proteins is 15.6% with roughly equal contributions from each
protease data set (Figure S1B).
Identification of Predicted Proteins and Protein
Isoforms
Approximately 5,700 unique peptides (Table S8A) provide exper-
imental evidence for 1,195 in silico predicted GENSCANproteins
(Table S7 and S8B). For 1,187 (99%) of those, RNA-seq data
support the observed expression. Fifty of them show best recip-
rocal hits with known mouse proteins, and another 32 with
known human proteins (Table S8C). Furthermore, we detect
N-terminally acetylated peptides for 69 of these 1,187 proteins,
with A, M, S, and T as their N-terminal residues (Table S8D) (Dor-
meyer et al., 2007; Starheim et al., 2012). N-terminal peptides
validate these putative genes by confirming their translational
start sites. A different class of proteins with largely uncertain ex-
istence is the short expressed proteins (SEPs) encoded by short
open reading frames (Slavoff et al., 2013). Of all peptides in our
data set, 0.25% could be assigned to 86 known SEPs and 37
identified SEPs (Figure S2; Tables S7 and S8B).
The proteomics data also provide support for 83 transcript
splicing events (0% FDR) that were previously not annotated
(Figure 1D; Tables S6C, S7, S10A, and S10D). From all predicted
proteins and splice isoform identifications, 309 and 15 respec-
tively were unique for BN-Lx, and 193 and 13 were specific to
SHR (Table S6C).
Detection of Nonsynonymous Protein Variants
Next, we explored to what extent the addition of strain-specific
variants affected protein detectability and stability. Of the
uniquely assigned spectra, 3.5% did discriminate between
allele-specific protein isoforms. We detected 126 nonsynony-
mous variants in our proteomic data, 38 for BN-Lx, and 88 for
SHR (Tables S10A and S10B). By applying a 0% FDR cutoff,
we reassuringly did not find any BN-Lx variants in the SHR sam-
ples, and vice versa (Table S6C). The fact that only a portion of
nonsynonymous variants was confirmed by peptide-based evi-
dence can be explained by our experimental design in which
only genes expressed in the liver could be detected. Clearly,
the inclusion of allele-specific variants has a measurable impact
on protein discovery and results in more balanced peptide count
per strain. The latter is most notable for the SHR rat because its
genome is more diverged from the reference strain (BN).
We used SIFT and Polyphen2 to predict if nonsynonymous
SNVs could affect protein stability (Tables S9 and S11). Poten-
tially damaging mutations were clearly overrepresented in differ-
entially expressed proteins with nondifferential transcript levels1472 Cell Reports 5, 1469–1478, December 12, 2013 ª2013 The Aut(p < 0.002) (Table S11). This illustrates that nonconservative
and structural missense variants may have limited influence on
the abundance of a transcript yet can show a pronounced effect
on protein stability.
Peptide-Based Evidence for RNA Editing
To identify functional RNA-editing events, we mapped our pep-
tide spectra to the set of potential RNA-editing events. In total,
20 out of the 196 nonsynonymous editing events could be
confirmed by unique peptide-based evidence (Tables S6C, S9,
S10A, and S10C). Because unique peptide evidence needs to
overlap with the predicted editing site, many of the remaining
176 edits are likely missed because of incomplete coverage or
redundancy in peptide data. Whereas limitations in the MS tech-
nology obviously result in an underrepresentation of identified
RNA edits, MS still provides the best means to confirm the pres-
ence of such posttranscriptional modifications in the expressed
proteins. On the other hand, we cannot rule out a possibility that
the relatively low percentage of confirmed events is a true repre-
sentation of the actual level of posttranscriptional modifications
that make it to mature proteins. This may be due to negative
selection against modified mRNA molecules. The high level of
RNA sequencing coverage and the strict calling settings used
to define editing events make it unlikely that an overestimation
of editing events is introduced during the RNA sequencing pro-
cedure and analysis.
It is worth noting that our comparison of de novo assembled
and the annotated transcriptomes may not only reveal genetic
differences, transcript isoforms, and common edited sites.
Sequence and annotation imperfections within the current
assembly and gene build can also be detected because the pro-
teogenomics approach used in this study accounts for differ-
ences between observed and annotated transcriptome that
originate from both biological and technical sources. Also, we
emphasize that the de novo transcriptome assembly approach
should be supplemented by regular transcriptome profiling if
one aims to discover transcript variants that correspond to
low-abundance transcripts and low-frequency events. To this
end, we performed direct alignment of RNA-seq data to the
rat transcriptome (known proteins and GENSCAN predictions)
and predicted additional modifications of annotated transcripts
(Table S5).
Relation between Transcriptome and Proteome Levels
Next, we studied quantitative aspects by investigating the
abundance of mRNA and protein levels. Although being derived
from two different strains of rats, we observed a very high
correlation of liver mRNA between BN-Lx and SHR (r = 0.98).
Similarly, the correlation coefficient for protein expression be-
tweenBN-Lx andSHR is also remarkably high (r = 0.94) (Figure 2),
providing confidence in our quantification strategy based on
spectral counts.
Next, we sought to define a correlation between mRNA and
protein expression levels in our data. Making a direct correlation
between mRNA and protein levels is hampered by the fact that
in peptide-based proteomics many proteins contain similar
peptide sequences. It is therefore hard to assign any of the
shared peptides unambiguously to a protein, the so-calledhors
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Figure 2. Global Correlation Plots Displaying the Complexity of mRNA and Protein Abundance
(A) The top two panels display the high correlations between BN-Lx and SHR mRNA (left, r = 0.98) and protein levels (right, r = 0.94), estimated using log10
normalized spectral counts (Log10SAF) and normalized RNA seq counts (Log10FPKM). The bottom two panels show the poor correlations between mRNA and
protein abundance for BN-Lx (r = 0.43) and SHR (r = 0.42), respectively.
(B) Scatterplot depicting the correlation between experimentally determined gene-specificmRNA to protein abundance conversion factors as calculated for both
BN-Lx and SHR (r = 0.88).
See also Table S15.protein-inference problem (Grobei et al., 2009; Nesvizhskii and
Aebersold, 2005). Consequently, it is hard to integrate the
quantitative measurements, which are necessarily restricted to
peptides, to a protein measurement. Still, numerous studies
conclude that the global correlation between mRNA and protein
is certainly not linear and often an r of 0.4–0.5 is reported (Ning
et al., 2012; de Sousa Abreu et al., 2009; Vogel and Marcotte,
2012). Such findings are corroborated by results that show that
indeed only part of the variation in the protein levels can be ex-
plained by mRNA levels (Schwanha¨usser et al., 2011). Here,
we use a spectra-count method for quantification of protein
levels. We use data derived from five different proteolytic en-
zymes, which is sufficient to exclude a proteolytic digest-specific
bias (Peng et al., 2012). Although we did identify unique peptides
per protein (Table S12), we chose to take the total number of
PSMs for every peptide matching a protein as a measurement
of its abundance to increase the quantitative resolution per pro-
tein. Subsequently, we determined the proteome-transcriptome
correlation for BN-Lx and SHR to be r = 0.43 and 0.42, respec-
tively (Figure 2A). This correlation is thus weak, albeit in line
with the previous studies in other systems. Based on these quan-
titative comparisons, we also found that 30 UTR expression
levels correlate increasingly better with protein levels (r = 0.54)
than do 50 UTR levels (r = 0.43) or reads derived from the coding
sequence (r = 0.47) (Figures S3C–S3E). We speculate that theCell Reabundance of 30 UTR reads depends on transcript integrity and
reflects both transcript count and stability. Transcript levels
could also be reproducibly converted to predicted protein levels
using a gene-specific conversion factor, which showed high cor-
relation between the two strains (r = 0.88) (Figure 2B; Table S15).
The high correlation between strains for this gene-specific factor
illustrates the conservation of quantitative mRNA levels in rela-
tion to protein levels, independent of intermediate (less under-
stood) levels of expression regulation. Although the conversion
factor cannot be analyzed in-depth within the scope of this
article, we postulate that translation efficiency, RNA, and protein
degradation (and thus stability) are likely to play an important
role. The top 100 proteins with the lowest and highest conversion
factors were subjected to gene ontology (GO) overrepresenta-
tion analysis. We observed a trend in cellular localization toward
cytoskeleton (highest 100) or the membrane (lowest 100),
although the observations were not significant (Figure S3B;
Table S15). We can only speculate that the conversion factor
appears to be protein specific and conserved between strains.
This factor combines the aforementioned levels of gene expres-
sion regulation in one value. One particular group of proteins
appears to behave differently, representing the family of a2u-
globulins (known as rat major urinary proteins; Figures S3A
and S3B). Unfortunately, none of these proteins could be identi-
fied by unique peptides due to high protein sequence homologyports 5, 1469–1478, December 12, 2013 ª2013 The Authors 1473
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Figure 3. Gene-Centric Strain-to-Strain Com-
parison of Significantly Differentially Ex-
pressed Genes
(A) Genes in BN-Lx and SHR with significantly
deviating mRNA levels (blue dots; n = 59) or mRNA
and protein levels (red dots; n = 54) are highlighted.
Gene names marked by an asterisk are based
on GENSCAN blast predictions derived from
the closest predicted homology to human and
mouse genes. Genes belonging to the CYP450
superfamily of catalytic enzymes are in bold and
genes associated with hypertension in human or rat
literature (Hao2, Serpina3m, Cyp8b1, and Cyp17a1)
are underscored.
(B) Western blot performed with liver tissues from
five animals each for BN-Lx and SHR. Both Cyp17a1
and Hao2 are downregulated in all the biological
replicates in the SHR strain compared to BN-Lx,
consistent with the proteomics data. Actin was used
as a loading control.
See also Tables S7 and S13.within this class of genes. Therefore, although this class stands
out in the quantitative comparisons, absolute differences be-
tween BN-Lx and SHR cannot be determined with high confi-
dence at this point.
Genetic Control of Quantitative Proteome
Characteristics
To determine the effects of genetic variation on quantitative
transcriptome and proteome characteristics, we compared the
difference of mRNA and protein expression between the two
rat strains. First, we filtered our quantitative data with more strin-
gent criteria retaining only genes quantifiable at both the protein
and the RNA level (reliable expression level estimates by Cuffdiff
and nonzero SAF counts). This allowed us to compare 6,743
genes (Figure 3A; Table S13), 113 of which were differentially ex-
pressed at the RNA level (at least 2-fold change in expression;
and q < 0.01) and 205 at the protein level (at least 2-fold change
and q = 0). Themajority of the differentially expressed transcripts
(59/113) do not show comparable changes at proteomics level.
This group of proteins likely acquires stable expression through
regulation of at the level of translation or through proteostasis.
A small proportion of the genes (13/113) shows discordant1474 Cell Reports 5, 1469–1478, December 12, 2013 ª2013 The Authorsbehavior with opposite expression pat-
terns for transcripts and proteins. Both
groups do not show any overrepresenta-
tion in GO terms or pathways. The limited
number of genes with significantly altered
expression indicates the high global
genome and proteome similarity between
the two inbred rat strains. However, it also
illustrates that interindividual differences
may be in the details, such as repre-
sented by changes in posttranslational
protein modifications and protein net-
works (Altelaar et al., 2013; Bensimon
et al., 2012). Finally, 41 out of the 113
differential genes show strain-specificexpression changes that are consistent between transcriptome
and proteome (Figure 3A; Table S13). The products of these 41
genes relate to catalytic activity (28 genes, GO-term enrichment
p value 1.4e-5) and metabolic pathways (13 genes, p = 2.6e-4).
A Germline Promoter Variant Deregulates Cyp17a1
Expression in Spontaneously Hypertensive Rats
This set of 41 genes likely underlies some of the phenotypic dif-
ferences known to exist between BN-Lx and SHR rats, like spon-
taneous hypertension (Okamoto and Aoki, 1963) and metabolic
syndrome (Aitman et al., 1997, 1999). We therefore investigated
which genes were previously reported to be associated with hy-
pertension in human or rat. First, three out of the 41 genes that
are differential at both the mRNA and protein level were found
to be associated with hypertension in the rat. Those three genes,
Hao2 (Lee et al., 2003), Serpina3m, and Cyp8b1 (Kinoshita et al.,
2011), came out as top hits when studying SHR (-related)
strains or a panel of congenic rat strains to define candidates
for hypertension. All three genes also overlap known blood pres-
sure QTLs in the rat (Dwinell et al., 2009), and two of them
(Serpina3m and Hao2) show a very strong connection to the
SHR genotype based on eQTL data derived from the BXH/HXB
B
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Figure 4. A Germline Promoter Variant Deregulates Cyp17a1 Expression in Spontaneously Hypertensive Rats
(A) Experimental evidence covering this part of the genome from RNA sequencing and the proteomics data (spectral counts) are plotted along the gene body of
Cyp17a1 for BN-Lx (blue) and SHR (red). The transcript is positioned on the reverse strand. Both the annotated transcription start site (TSS, black arrow) and the
actual TSS (gray arrow) are shown.
(B) Expression QTL analysis of Cyp17a1 expression in the HXB/BXH recombinant inbred panel. Gene expression is plotted based on RNA-seq for the ancestral
strains (n = 5) and the RI strains split by ancestral haplotype at the Cyp17a1 locus (n = 16 for BN-Lx and n = 14 for SHR).
(C) Zoomed-in view of the actual TSS, with the position of the germline T/C SNV shown. The dashed box (gray) shows the core part of the forkhead box DNA
binding motif.
(D) Consensus forkhead box DNA binding motif, obtained from the JASPAR database FOXA1 motif (Sandelin et al., 2004).
See also Table S14.recombinant inbred panel (founded by the BN-Lx and SHR
strains) (Figure S4A–S4C). This implies that the gene expression
regulation of Serpina3m and Hao2 is regulated in cis and thus
strongly related to the genotype of the SHR strain. A fourth
gene, Cyp17a1, was identified as a top hit in relation to blood
pressure and hypertension in human genome-wide association
studies on European, Japanese, and Chinese individuals (Li
et al., 2013; Liu et al., 2011; Newton-Cheh et al., 2009; Takeuchi
et al., 2010) (Table S14A). Cyp17a1 also overlaps a blood pres-
sure QTL in the rat and shows the most extreme downregulation
in SHR compared to BN-Lx in our analysis (Figure 3A). The differ-
ential expression of Hao2 and Cyp17a1 was verified indepen-
dently by western blot, using liver samples of five animals from
each strain (Figure 3B). Like Cyp8b1, Cyp17a1 is a member of
the cytochrome P450 (CYP450) superfamily (Danielson, 2002)
of catalytic enzymes that mediate monooxygenase reactions
and regulate drugmetabolism. Interestingly, mutations in human
CYP17A1 are known to lead to congenital adrenal hyperplasiaCell Redue to 17 alpha-hydroxylase deficiency, which results in hypo-
gonadism, pseudohermaphroditism, and severe hypertension
(Biglieri, 1997; Biglieri et al., 1966; Geller et al., 1997; Goldsmith
et al., 1967). To determine the genetic basis of the Cyp17a1
expression differences between BN-Lx and SHR, we sought
for genetic variants in the annotated exons and flanking regula-
tory sequences, but none were present. Exploration of eQTL
data, however, revealed a very strong cis-effect (Figure 4B;
Table S14B), indicating that the measured expression difference
is due to genetic variants in the gene itself or in neighboring
regulatory elements. Upon closer inspection of the RNA-seq
data, we found that the transcriptional start site (TSS) of the
Cyp17a1 gene was incorrectly annotated and resides approxi-
mately 2 kb upstream of the currently annotated most 50 exon
(Figure 4A). The true location of the promoter could be confirmed
by H3K4me3 ChIP data that show specific enrichment of this
active promoter mark surrounding the nucleosome-free region
of the unannotated TSS (Figure S4D). Interestingly, this promoterports 5, 1469–1478, December 12, 2013 ª2013 The Authors 1475
does harbor a germline variant in SHR that disrupts the core part
of an evolutionary conserved forkhead-box DNA binding domain
(Figures 4C and 4D) (Sandelin et al., 2004), specifically deregu-
lating transcription in SHR (Figure 4A). Because this expression
trait is regulated in cis and this SNV is the only germline variant
in the vicinity of the gene, our integrated genomics, transcrip-
tomics, and proteomics approach has most likely identified the
source of expression variation. The overlap with the RGD blood
pressure QTL (http://rgd.mcw.edu/), top GWAS loci in humans,
and known link to hypertension as a result of renal hyperplasia
in patients carrying CYP17A1 mutations are good indications
that this promoter mutation in the SHR Cyp17a1 gene contrib-
utes to the observed hypertensive phenotype of SHR rats.
Conclusions
Technological advances in both the proteomics and the
sequencing community now provide the ability to discriminate
genetic and posttranscriptional polymorphisms at the proteome
level. These advances also allow improved quantitation of gene
expression, which is generally restricted by the imprecise proxy
of transcriptome data alone. We here show that the synergistic
use of genomic, transcriptomic, and proteomic technologies
significantly improves the information load that can be gained
from proteomics as well as genomics efforts. By matching
deep MS-based proteomics to a personalized database built
from a sample-specific genome and transcriptome, we identify
thousands of peptides that would otherwise escape identifica-
tion. We believe that future efforts on both platforms benefit
largely from our proof-of-concept approach, which brings
integrated proteogenomics to a higher level. To highlight the
strength of this approach, we present a link of a genomic variant
in the Cyp17a1 gene promoter and associate it with the hyper-
tension phenotype of the extensively studied SHR rats.
EXPERIMENTAL PROCEDURES
An extended version of the experimental procedures can be found in the Sup-
plemental Information.
Custom Rat Protein Database Construction
We modified and appended the Ensembl (Birney et al., 2004; Curwen et al.,
2004; Hubbard et al., 2002) rat protein FASTA (build 3.4.63), whichwas derived
from the reference (BN) genome assembly, with DNA resequencing and
RNA-seq data of the BN-Lx and SHR strains. Single nucleotide variants and in-
dels were obtained from previous genome sequencing efforts (Atanur et al.,
2010; Simonis et al., 2012). RNA was isolated from liver tissues of 6-week-
old inbred BN-Lx/Cub and SHR/OlaIpcv rats. SOLiD RNA-seq libraries were
prepared with ribosomal RNA depleted RNA and sequenced on the SOLiD
V4 system. Next, we used CLC assembly cell version 4 (CLC Bio) to de novo
assemble each rat liver transcriptome.MergedBN-Lx andSHR transcriptomes
were mapped against the reference genome assembly using BLAT software
(Kent, 2002). Splicing and RNA-editing events were detected using alignments
between the assembled transcriptomeandgenomeandcompared to their cor-
responding proteins. For all nonsynonymous genomic and transcriptome var-
iants, individual entries were added to the extended protein search database.
Also, we included 44,993 GENSCAN gene predictions of which 17,100
(FPKM >0.1) or 4,998 (FPKM >1.0) show evidence of expression.
Quantification of Transcriptome Data and Identification of eQTLs
To quantify expression differences, RNA-seq data for each sample were
aligned to reference genome using TopHat2. Expressed and differentially ex-1476 Cell Reports 5, 1469–1478, December 12, 2013 ª2013 The Autpressed genes were defined by Cuffdiff using all four transcriptomes per strain
(Trapnell et al., 2012). Determination of eQTLs in the HXB/BXH recombinant
inbred panel consisting of 30 rat strains was performed exactly as previously
described (Heinig et al., 2010).
Strong Cation Exchange Chromatography
After sonication and centrifugation, liver tissue lysates (300 mg each) were pro-
teolyzed using trypsin, LysC, GluC, AspN, and chymotrypsin. After desalting,
peptides were fractionated using a strong cation exchange (SCX) column
(Zorbax BioSCX-Series II; 0.8 mm inner diameter 3 50 mm length, 3.5 mm),
and 36 fractions were collected per digest.
Mass Spectrometry Analysis
The first 26 fractions were analyzed with an Agilent 1290 Infinity (Agilent Tech-
nologies) LC, operating in reverse-phase (C18) mode, coupled to a TripleTOF
5600 (AB Sciex). MS spectra (350–1,250 m/z) were acquired in high-resolution
mode (R > 30,000), whereas MS2 in high-sensitivity mode (R > 15 000). The
next ten fractions were analyzed with a Proxeon EASY-nLC 1000 (Thermo
Scientific) operating in reverse phase (C18) and connected to an LTQ-Orbitrap
Velos (Thermo Fisher Scientific). For MS analysis, MS spectra (350–1,500 m/z)
were acquired at a resolution of 30,000 and for MS2, R = 7,500.
Protein Database Searching
Peak lists (MGFs) were submitted to the Mascot (version 2.3) via Proteome
Discoverer version 1.3 (Thermo Fisher Scientific) and searched against RAT_
COMBINED with the respective proteases chosen. Peptide tolerance was
50 ppm, and MS/MS tolerance was 0.1 Da (TOF), 0.02 Da (Orbitrap), and
0.5 Da (ion trap). All PSMs were validated with Percolator (Ka¨ll et al., 2007)
based on q = 0 (0% FDR). Only PSMs ranked first by the search engine with
at least six amino acids were kept. Unmatched spectra were exported for anal-
ysis with PEAKS Studio (version 6.0). Peak lists were filtered with a quality
value of 0.65, followed by a tag database search. The maximum allowed var-
iable PTM per peptide was set to 3. De novo interpreted PSMswere submitted
to PEAKS DB database matching, allowing semienzymatic specificity and a
maximum cleavage per peptide of 2. The FDR was estimated using a concat-
enated decoy database and according to a threshold of 0.0%.
Quantitative Comparison of Proteome and Transcriptome Data
To combine quantitative data from all methods, we developed a relational
database schema (Figure S8) for data storage. The database schema was
converted to Java (Java SE 7, Oracle) entities, using Java Persistence API
(JPA version 2) implemented in EclipseLink version 2.3.2 (http://www.
eclipse.org/eclipselink), with the tools provided in Netbeans IDE 7.3 (http://
www.netbeans.org). The database used was MySQL version 5.5 (Oracle).
ACCESSION NUMBERS
The ProteomeXchange (Vizcaı´no et al., 2013) accession number for the MS
data reported in this paper is PXD000131. The Sequence Read Archive acces-
sion numbers for the DNA data are ERP001355 (BN-Lx genome), ERP001371
(SHR genome), and ERP000510 (BN reference genome). RNA sequencing
data were stored in ArrayExpress under the accession number E-MTAB-1666.
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